Longitudinal microSPECT/CT imaging and pharmacokinetics of synthetic luteinizing hormone-releasing hormone (LHRH) vaccine in rats

Anticancer Research

Volumn 27, Issue 5 A, 2007, Pages 3251-3257

  Chang, Chih Hsien ^a   Hsu, Wei Chuan ^a   Wang, Chang Yi ^b   Jan, Meei Ling ^a   Tsai, Tung Hu ^c   Lee, Te Wei ^a   Lynn, Shu Gene ^b   Yeh, Chung Hsin ^a   Chang, Tsui Jung ^a  

^a INSTITUTE OF NUCLEAR ENERGY RESEARCH   (Taiwan)

^b United Biomedical Inc   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Luteinizing hormone releasing hormone; Micro computed tomography (microCT); Micro single photon emission computed tomography (microSPECT); Vaccine

Indexed keywords

CANCER VACCINE; GONADORELIN; IMMUNOLOGICAL ADJUVANT; IODINE 131; IODINE 131 P500; IODINE 131 P607E; IODINE 131 P667; MONTANIDE ISA50; RADIOISOTOPE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG ELIMINATION; DRUG HALF LIFE; IMMUNOGENICITY; ISOTOPE LABELING; MALE; NONHUMAN; PRIORITY JOURNAL; RADIOACTIVITY; RADIOCHEMISTRY; RAT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ANIMALS; CANCER VACCINES; EPITOPES, T-LYMPHOCYTE; GONADOTROPIN-RELEASING HORMONE; IODINE RADIOISOTOPES; ISOTOPE LABELING; LONGITUDINAL STUDIES; MALE; PROSTATIC NEOPLASMS; RATS; RATS, SPRAGUE-DAWLEY; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VACCINES, SYNTHETIC;

EID: 35349012690     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Talwar GP: Vaccines for control of fertility and hormone-dependent cancers. Immunol Cell Biol 75: 184-189, 1997.
2. Finstad CL, Wang CY, Kowalski J, Zhang M, Li ML, Li XM, Xia WG, Bosland MC, Murthy KK, Walfield AM, Koff WC and Zamb TJ: Synthetic luteinizing hormone releasing hormone (LHRH) vaccine for effective androgen deprivation and its application to prostate cancer immunotherapy. Vaccine 22: 1300-1313, 2004.
3. Imam SK: Molecular nuclear imaging: the radiopharmaceuticals (review). Cancer Biother Radiopharm 20: 163-172, 2005.
4. Rudin M and Weissleder R: Molecular imaging in drug discovery and development. Nat Rev Drug Discov 2: 123-131, 2003.
5. Oh P, Li Y, Yu J, Durr E, Krasinska KM, Carver LA, Testa JE and Schnitzer JE: Subtractive proteomic mapping of the endothelial surface in lung and solid tumours for tissue-specific therapy. Nature 429: 629-635, 2004.
6. Macklis RM: Iodine-131 tositumomab (Bexxar) in a radiation oncology environment. Int J Radiat Oncol Biol Phys 66: S30-34, 2006.
7. Shinitzky M and Fridkin M: Structural features of luliberin (luteinising hormone-releasing factor) inferred from fluorescence measurements. Biochim Biophys Acta 434: 137-143, 1976.
8. Wang CY, Chang TY, Walfield AM, Ye J, Shen M, Chen SP, Li MC, Lin YL, Jong MH, Yang PC, Chyr N, Kramer E and Brown F: Effective synthetic peptide vaccine for foot-and-mouth disease in swine. Vaccine 20: 2603-2610, 2002.
9. Greenstein JL, Schad VC, Goodwin WH, Brauer AB, Bollinger BK, Chin RD and Kuo MC: A universal T cell epitope-containing peptide from hepatitis B surface antigen can enhance antibody specific for HIV gp120. J Immunol 148: 3970-3977, 1992.
10. Partidos CD, Stanley CM and Steward MW: Immune responses in mice following immunization with chimeric synthetic peptides representing B and T cell epitopes of measles virus proteins. J Gen Virol 72(Pt 6): 1293-1299, 1991.
11. Demotz S, Lanzavecchia A, Eisel U, Niemann H, Widmann C and Corradin G: Delineation of several DR-restricted tetanus toxin T cell epitopes. J Immunol 142: 394-402, 1989.
12. Salacinski PR, McLean C, Sykes JE, Clement-Jones VV and Lowry PJ: Iodination of proteins, glycoproteins, and peptides using a solid-phase oxidizing agent, 1,3,4,6-tetrachloro-3 alpha,6 alpha-diphenyl glycoluril (Iodogen). Anal Biochem 117: 136-146, 1981.
13. Behr TM, Gotthardt M, Becker W and Behe M: Radioiodination of monoclonal antibodies, proteins and peptides for diagnosis and therapy. A review of standardized, reliable and safe procedures for clinical grade levels kBq to GBq in the Gottingen/Marburg experience. Nuklearmedizin 41: 71-79, 2002.
14. Subbarayan M, Hafeli UO, Feyes DK, Unnithan J, Emancipator SN and Mukhtar H: A simplified method for preparation of 99mTc-annexin V and its biologic evaluation for in vivo imaging of apoptosis after photodynamic therapy. J Nucl Med 44: 650-656, 2003.
15. Caster WO, Poncelet J, Simon AB and Armstrong WD: Tissue weights of the rat. I. Normal values determined by dissection and chemical methods. Proc Soc Exp Biol Med 91: 122-126, 1956.
16. Jan ML, Chuang KS, Chen GW, Ni YC, Chen S, Chang CH, Wu J, Lee TW and Fu YK: A three-dimensional registration method for automated fusion of micro PET-CT-SPECT whole-body images. IEEE Trans Med Imaging 24: 886-893, 2005.
17. Jung MJ, Moon YC, Cho IH, Yeh JY, Kim SE, Chang WS, Park SY, Song CS, Kim HY, Park KK, McOrist S, Choi IS and Lee JB: Induction of castration by immunization of male dogs with recombinant gonadotropin-releasing hormone (GnRH)-canine distemper virus (CDV) T helper cell epitope p35. J Vet Sci 6: 21-24, 2005.
18. Zeng XY, Turkstra JA, Meloen RH, Liu XY, Chen FQ, Schaaper WM, Oonk HB, Guo da Z and van de Wiel DF: Active immunization against gonadotrophin-releasing hormone in Chinese male pigs: effects of dose on antibody titer, hormone levels and sexual development. Anim Reprod Sci 70: 223-233, 2002.
19. Clayton RN, Shakespear RA, Duncan JA, Marshall JC, Munson PJ and Rodbard D: Radioiodinated nondegradable gonadotropin-releasing hormone analogs: new probes for the investigation of pituitary gonadotropin-releasing hormone receptors. Endocrinology 105: 1369-1376, 1979.
20. Perrin MH, Haas Y, Rivier JE and Vale WW: Gonadotropin-releasing hormone binding to rat anterior pituitary membrane homogenates. Comparison of antagonists and agonists using radiolabeled antagonist and agonist. Mol Pharmacol 23: 44-51, 1983.
21. Flanagan CA, Fromme BJ, Davidson JS and Millar RP: A high affinity gonadotropin-releasing hormone (GnRH) tracer, radioiodinated at position 6, facilitates analysis of mutant GnRH receptors. Endocrinology 139: 4115-4119, 1998.
22. Bramley TA, Boyle HP and Menzies GS: Human placental GnRH-like factors: parallel displacement in GnRH immuno-and receptor-binding assays can be caused by degradation of radiolabelled GnRH tracers. Mol Hum Reprod 5: 1095-1106, 1999.
23. Jaeger LB, Banks WA, Varga JL and Schally AV: Antagonists of growth hormone-releasing hormone cross the blood-brain barrier: a potential applicability to treatment of brain tumors. Proc Natl Acad Sci USA 102: 12495-12500, 2005.
24. Schwahn M, Schupke H, Gasparic A, Krone D, Peter G, Hempel R, Kronbach T, Locher M, Jahn W and Engel J: Disposition and metabolism of cetrorelix, a potent luteinizing hormone-releasing hormone antagonist, in rats and dogs. Drug Metab Dispos 28: 10-20, 2000.
25. Behr TM, Goldenberg DM and Becker WS: Radioimmunotherapy of solid tumors: a review "of mice and men". Hybridoma 16: 101-107, 1997.